Literature DB >> 29336782

Loss of GPNMB Causes Autosomal-Recessive Amyloidosis Cutis Dyschromica in Humans.

Chi-Fan Yang1, Shuan-Pei Lin2, Chien-Ping Chiang3, Yu-Hung Wu4, Weng Siong H'ng1, Chun-Ping Chang1, Yuan-Tsong Chen1, Jer-Yuarn Wu5.   

Abstract

Amyloidosis cutis dyschromica (ACD) is a distinct form of primary cutaneous amyloidosis characterized by generalized hyperpigmentation mottled with small hypopigmented macules on the trunks and limbs. Affected families and sporadic case subjects have been reported predominantly in East and Southeast Asian ethnicities; however, the genetic cause has not been elucidated. We report here that the compound heterozygosity or homozygosity of GPNMB truncating alleles is the cause of autosomal-recessive ACD. Six nonsense or frameshift mutations were identified in nine individuals diagnosed with ACD. Immunofluorescence analysis of skin biopsies showed that GPNMB is expressed in all epidermal cells, with the highest staining observed in melanocytes. GPNMB staining is significantly reduced in the lesional skin of affected individuals. Hyperpigmented lesions exhibited significantly increased amounts of DNA/keratin-positive amyloid deposits in the papillary dermis and infiltrating macrophages compared with hypo- or depigmented macules. Depigmentation of the lesions was attributable to loss of melanocytes. Intracytoplasmic fibrillary aggregates were observed in keratinocytes scattered in the lesional epidermis. Thus, our analysis indicates that loss of GPNMB, which has been implicated in melanosome formation, autophagy, phagocytosis, tissue repair, and negative regulation of inflammation, underlies autosomal-recessive ACD and provides insights into the etiology of amyloidosis and pigment dyschromia.
Copyright © 2017 American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  DBA/2J; GPNMB; Glycoprotein nonmetastatic gene B; PMEL; amyloid; amyloidosis cutis dyschromica; glaucoma; hyperpigmentation; hypopigmentation; pigment dispersion

Mesh:

Substances:

Year:  2018        PMID: 29336782      PMCID: PMC5985536          DOI: 10.1016/j.ajhg.2017.12.012

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  55 in total

1.  Hematopoietic growth factor inducible neurokinin-1 type: a transmembrane protein that is similar to neurokinin 1 interacts with substance P.

Authors:  Persis S Bandari; Jing Qian; Ghassan Yehia; Deval D Joshi; Paul B Maloof; Julius Potian; Hyun S Oh; Pedro Gascon; Jonathan S Harrison; Pranela Rameshwar
Journal:  Regul Pept       Date:  2003-03-28

2.  The melanoma-associated transmembrane glycoprotein Gpnmb controls trafficking of cellular debris for degradation and is essential for tissue repair.

Authors:  Bing Li; Ana P Castano; Thomas E Hudson; Brian T Nowlin; Shuei-Liong Lin; Joseph V Bonventre; Kenneth D Swanson; Jeremy S Duffield
Journal:  FASEB J       Date:  2010-08-13       Impact factor: 5.191

3.  DC-HIL is a negative regulator of T lymphocyte activation.

Authors:  Jin-Sung Chung; Kota Sato; Irene I Dougherty; Ponciano D Cruz; Kiyoshi Ariizumi
Journal:  Blood       Date:  2007-02-06       Impact factor: 22.113

4.  Amyloidosis cutis dyschromica. DNA repair reduction in the cellular response to UV light.

Authors:  S Moriwaki; C Nishigori; Y Horiguchi; S Imamura; K Toda; H Takebe
Journal:  Arch Dermatol       Date:  1992-07

5.  Nucleic acid-containing amyloid fibrils potently induce type I interferon and stimulate systemic autoimmunity.

Authors:  Jeremy Di Domizio; Stephanie Dorta-Estremera; Mihai Gagea; Dipyaman Ganguly; Stephan Meller; Ping Li; Bihong Zhao; Filemon K Tan; Liqi Bi; Michel Gilliet; Wei Cao
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-17       Impact factor: 11.205

6.  Osteoactivin, an anabolic factor that regulates osteoblast differentiation and function.

Authors:  Samir M Abdelmagid; Mary F Barbe; Mario C Rico; Sibel Salihoglu; Israel Arango-Hisijara; Abdul Hafez Selim; Michael G Anderson; Thomas A Owen; Steven N Popoff; Fayez F Safadi
Journal:  Exp Cell Res       Date:  2008-03-10       Impact factor: 3.905

7.  Targeted overexpression of osteoactivin in cells of osteoclastic lineage promotes osteoclastic resorption and bone loss in mice.

Authors:  Matilda H-C Sheng; Jon E Wergedal; Subburaman Mohan; Mehran Amoui; David J Baylink; K-H William Lau
Journal:  PLoS One       Date:  2012-04-20       Impact factor: 3.240

8.  Functional amyloid formation within mammalian tissue.

Authors:  Douglas M Fowler; Atanas V Koulov; Christelle Alory-Jost; Michael S Marks; William E Balch; Jeffery W Kelly
Journal:  PLoS Biol       Date:  2006-01       Impact factor: 8.029

9.  Silencing of GPNMB by siRNA inhibits the formation of melanosomes in melanocytes in a MITF-independent fashion.

Authors:  Ping Zhang; Wei Liu; Cansheng Zhu; Xiaoying Yuan; Dongguang Li; Weijie Gu; Huimin Ma; Xin Xie; Tianwen Gao
Journal:  PLoS One       Date:  2012-08-13       Impact factor: 3.240

10.  Beta amyloid oligomers and fibrils stimulate differential activation of primary microglia.

Authors:  Cindy M Sondag; Gunjan Dhawan; Colin K Combs
Journal:  J Neuroinflammation       Date:  2009-01-05       Impact factor: 8.322

View more
  11 in total

Review 1.  Glycoprotein nonmetastatic melanoma protein B: A key mediator and an emerging therapeutic target in autoimmune diseases.

Authors:  Pei-Suen Tsou; Amr H Sawalha
Journal:  FASEB J       Date:  2020-05-23       Impact factor: 5.191

Review 2.  Diagnosis of Primary Cutaneous Amyloidosis by Rapid 4,6-Diamidino-2-Phenylindole Staining.

Authors:  Junchen Chen; Huan Yang; Zhijun Xu; Ping Lu; Liyan Yuan; Yaohua Xue; Ruzeng Xue; Bin Yang
Journal:  Dermatology       Date:  2021-08-26       Impact factor: 5.366

Review 3.  The Role of GPNMB in Inflammation.

Authors:  Marina Saade; Giovanna Araujo de Souza; Cristoforo Scavone; Paula Fernanda Kinoshita
Journal:  Front Immunol       Date:  2021-05-12       Impact factor: 7.561

4.  Targeted Multiple Reaction Monitoring Analysis of CSF Identifies UCHL1 and GPNMB as Candidate Biomarkers for ALS.

Authors:  Shaochun Zhu; Anna Wuolikainen; Junfang Wu; Anders Öhman; Gunnar Wingsle; Thomas Moritz; Peter M Andersen; Lars Forsgren; Miles Trupp
Journal:  J Mol Neurosci       Date:  2019-11-12       Impact factor: 3.444

Review 5.  Skin Pigmentation Abnormalities and Their Possible Relationship with Skin Aging.

Authors:  Ai-Young Lee
Journal:  Int J Mol Sci       Date:  2021-04-02       Impact factor: 5.923

Review 6.  Primary Localized Cutaneous Amyloidosis of Keratinocyte Origin: An Update with Emphasis on Atypical Clinical Variants.

Authors:  Lamiaa Hamie; Isabelle Haddad; Nourhane Nasser; Mazen Kurban; Ossama Abbas
Journal:  Am J Clin Dermatol       Date:  2021-07-21       Impact factor: 7.403

7.  Functional Domains and Evolutionary History of the PMEL and GPNMB Family Proteins.

Authors:  Paul W Chrystal; Tim Footz; Elizabeth D Hodges; Justin A Jensen; Michael A Walter; W Ted Allison
Journal:  Molecules       Date:  2021-06-09       Impact factor: 4.411

8.  OSMRβ mutants enhance basal keratinocyte differentiation via inactivation of the STAT5/KLF7 axis in PLCA patients.

Authors:  Jun Liu; Junchen Chen; Yadan Zhong; Xiaoling Yu; Ping Lu; Jianqi Feng; Xin Zhang; Shufeng Ma; Chao Yang; Bin Yang; Zhili Rong
Journal:  Protein Cell       Date:  2021-01-27       Impact factor: 14.870

9.  GPNMB is expressed in human epidermal keratinocytes but disappears in the vitiligo lesional skin.

Authors:  Kazal Boron Biswas; Aya Takahashi; Yukiko Mizutani; Satoru Takayama; Asako Ishitsuka; Lingli Yang; Fei Yang; Arunasiri Iddamalgoda; Ichiro Katayama; Shintaro Inoue
Journal:  Sci Rep       Date:  2020-03-18       Impact factor: 4.379

10.  Gene expression and functional deficits underlie TREM2-knockout microglia responses in human models of Alzheimer's disease.

Authors:  Amanda McQuade; You Jung Kang; Jonathan Hasselmann; Amit Jairaman; Alexandra Sotelo; Morgan Coburn; Sepideh Kiani Shabestari; Jean Paul Chadarevian; Gianna Fote; Christina H Tu; Emma Danhash; Jorge Silva; Eric Martinez; Carl Cotman; G Aleph Prieto; Leslie M Thompson; Joan S Steffan; Ian Smith; Hayk Davtyan; Michael Cahalan; Hansang Cho; Mathew Blurton-Jones
Journal:  Nat Commun       Date:  2020-10-23       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.